A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning

@article{Benesch2008ASS,
  title={A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning},
  author={Martin Benesch and Katharina Spiegl and Anita Winter and Andrea Passini and Herwig Lackner and Andrea Moser and Petra Sovinz and Wolfgang Schwinger and Christian Urban},
  journal={Child's Nervous System},
  year={2008},
  volume={25},
  pages={173-181}
}
The aim of this study was to quantify the severity of late effects by a simple numerical score (late effects severity score, LESS) in patients who received radiochemotherapy for medulloblastoma or ependymoma. The LESS was correlated with neurocognitive and quality of life (QoL) outcomes. The LESS was calculated by assigning 0, 1, or 2 points within each of four different categories (neurology, endocrine, visual/auditory, others). Twenty-three patients with medulloblastoma (n = 18) or ependymoma… CONTINUE READING